ConvaTec Group PLC (LON:CTEC)‘s stock had its “buy” rating restated by analysts at Deutsche Bank AG in a report issued on Monday, July 31st. They currently have a GBX 330 ($4.28) target price on the stock. Deutsche Bank AG’s price objective indicates a potential upside of 15.26% from the company’s current price.
A number of other research firms also recently weighed in on CTEC. Numis Securities Ltd reiterated a “hold” rating and issued a GBX 276 ($3.58) price target on shares of ConvaTec Group PLC in a research report on Thursday, May 4th. J P Morgan Chase & Co boosted their price objective on shares of ConvaTec Group PLC from GBX 305 ($3.96) to GBX 318 ($4.13) and gave the company an “overweight” rating in a research report on Friday, May 5th. Peel Hunt boosted their price objective on shares of ConvaTec Group PLC from GBX 300 ($3.89) to GBX 380 ($4.93) and gave the company a “buy” rating in a research report on Thursday, May 4th. Morgan Stanley restated an “equal weight” rating on shares of ConvaTec Group PLC in a research report on Thursday, May 4th. Finally, HSBC Holdings plc restated a “buy” rating and set a GBX 330 ($4.28) price objective on shares of ConvaTec Group PLC in a research report on Wednesday, April 26th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of GBX 312.33 ($4.05).
ConvaTec Group PLC (CTEC) opened at 286.30 on Monday. The stock has a 50 day moving average price of GBX 302.07 and a 200-day moving average price of GBX 288.40. ConvaTec Group PLC has a one year low of GBX 213.00 and a one year high of GBX 349.10. The firm’s market capitalization is GBX 5.59 billion.
ILLEGAL ACTIVITY WARNING: “ConvaTec Group PLC (LON:CTEC) Earns Buy Rating from Deutsche Bank AG” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at https://www.com-unik.info/2017/08/19/convatec-group-plc-lonctec-given-buy-rating-at-deutsche-bank-ag-updated-updated.html.
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
What are top analysts saying about ConvaTec Group PLC? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for ConvaTec Group PLC and related companies.